Researchers discovered that ovarian tumors hinder T cells’ energy supply by trapping a key protein, blocking lipid uptake. A new approach to reprogram T cells could enhance immunotherapy for aggressive cancers.
Researchers at Weill Cornell Medicine have uncovered a mechanism by which ovarian tumors weaken immune cells, effectively blocking their energy source and hindering their ability to launch an attack. Published on October 23 in Nature, this discovery offers a potential new immunotherapy strategy for ovarian cancer, a notoriously aggressive and challenging disease to treat.
A significant obstacle in treating ovarian cancer is the tumor microenvironment—the complex ecosystem of cells, molecules and blood vessels that shields cancer cells from the immune system. Within this hostile environment, T cells lose their ability to take up the lipid (fat) molecules, which are necessary for energy to mount an effective attack.
“T cells rely on lipids as fuel, burning them in their mitochondria to power their fight against pathogens and tumors,” explained senior author, Dr. Juan Cubillos-Ruiz, The William J. Ledger, M.D., Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology at Weill Cornell Medicine. “However, the molecular mechanisms that govern this critical energy supply are still not well understood.”
Identifying How Tumors Block T-Cell Energy Supply
Lipids are abundant in ovarian tumors, but T cells seem unable to utilize them in this environment. “Researchers have focused on a protein called fatty acid-binding protein 5, or FABP5, which facilitates lipid uptake, but its exact location within the T cell remained unclear,” said Dr. Sung-Min Hwang, a postdoctoral associate in Dr. Cubillos-Ruiz’s lab who led the new study. Dr. Hwang discovered that in patient-derived tumor specimens and mouse models of ovarian cancer, FABP5 becomes trapped inside the cytoplasm of T cells instead of moving to the cell surface, where it would normally help take up lipids from the surroundings.
“That was the ‘aha!’ moment; since FABP5 is not getting to the surface, it couldn’t bring in the lipids necessary for energy production. But we still needed to figure out why,” said Dr. Cubillos-Ruiz, who is also co-leader of the Cancer Biology Program in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.
Working with collaborators, the researchers used a battery of biochemical assays to identify proteins that bind to FABP5. They found a protein called Transgelin 2 that interacts with FABP5 and helps move it to the cell surface.
Further experiments revealed that ovarian tumors suppress the production of Transgelin 2 in infiltrating T cells. Delving deeper, the researchers discovered that the transcription factor XBP1, which is activated by the stressful conditions within the tumor, represses the gene encoding Transgelin 2. Without Transgelin 2, FABP5 is trapped in the cytoplasm of T cells, preventing lipid uptake and rendering the T cells unable to attack the tumor.
Designer Immunotherapies to Overcome Tumor Defenses
With this fundamental mechanism worked out, the team explored an immunotherapy called chimeric antigen receptor T (CAR T) cells. This approach collects a patient’s T cells, engineers them to attack tumor cells and then injects the designer cells into the patient. “CAR T cells work well against hematological cancers like leukemia and lymphoma, but they’re really not effective for solid tumors like ovarian or pancreatic cancers,” Dr. Cubillos-Ruiz said.
When Dr. Hwang and his colleagues tested CAR T cells, which are currently being evaluated in clinical trials, in mouse models of metastatic ovarian cancer, they found the same problem—Transgelin 2 repression and impaired lipid uptake. Just like normal T cells in the tumor microenvironment, the engineered CAR T cells had FABP5 tangled in the cytoplasm. As a result, the CAR T cells were unable to access lipids for energy to effectively attack the tumor, highlighting a critical barrier in using this immunotherapy for solid tumors like ovarian cancer.
To solve the problem, the researchers inserted a modified Transgelin 2 gene that couldn’t be blocked by stress transcription factors, so expression of the critical protein was preserved. This allowed Transgelin 2 to chaperone FABP5 to the surface of the CAR T cells where it could take up lipids.
Indeed, the upgraded T cells were much more effective in attacking ovarian tumors than the original CAR T cells. “Our findings reveal a key mechanism of immune suppression in ovarian cancer and suggest new avenues to improve the efficacy of adoptive T cell immunotherapies in aggressive solid malignancies,” Dr. Cubillos-Ruiz said.
Reference: “Transgelin 2 guards T cell lipid metabolism and antitumour function” by Sung-Min Hwang, Deepika Awasthi, Jieun Jeong, Tito A. Sandoval, Chang-Suk Chae, Yusibeska Ramos, Chen Tan, Matías Marin Falco, Camilla Salvagno, Alexander Emmanuelli, Ian T. McBain, Bikash Mishra, Lionel B. Ivashkiv, Dmitriy Zamarin, Evelyn Cantillo, Eloise Chapman-Davis, Kevin Holcomb, Diana K. Morales, Xiaoqing Yu, Paulo C. Rodriguez, Jose R. Conejo-Garcia, Martin Kaczocha, Anna Vähärautio, Minkyung Song and Juan R. Cubillos-Ruiz, 23 October 2024, Nature.
DOI: 10.1038/s41586-024-08071-y
This work was supported in part by the National Institutes of Health grants R01 NS114653, CA271619, CA282072, R01 CA237154 and R01 CA269382, the U.S. Department of Defense grants W81XWH2010191, W81XWH-16-1-0438, W81XWH-22-OCRP-IIRA, W81XWH2110478 and W81XWH2110357, and the American Association for Cancer Research; AACR-Bristol Myers Squibb Immuno-Oncology Research Fellowship.
News
World First: Stem Cell Transplant Restores Vision in Multiple People
A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind in the world, [...]
Clinical Trial: Mushroom Supplement May Halt Prostate Cancer Growth
The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use of white button mushrooms reduces the type of cells that suppress the immune system and facilitate the [...]
Scientists propose drug-free method to combat antibiotic-resistant bacteria
Recent estimates indicate that deadly antibiotic-resistant infections will rapidly escalate over the next quarter century. More than 1 million people died from drug-resistant infections each year from 1990 to 2021, a recent study reported, with [...]
New study shows how salmonella tricks gut defenses to cause infection
A new UC Davis Health study has uncovered how Salmonella bacteria, a major cause of food poisoning, can invade the gut even when protective bacteria are present. The research, published in the Proceedings of the National Academy [...]
Chlamydia vaccine shows early promise in mice
An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report. Lab mice given the vaccine were able to rapidly clear subsequent chlamydia infections, and were less likely to [...]
Contradictory Discovery: Our Innate Immune System May Fuel Cancer Development
MSK researchers discovered that the innate immune system’s chronic activation due to issues in the Mre11 complex can lead to cancer, highlighting new therapeutic targets. In addition to defending against pathogens, the body’s innate [...]
New study links circadian gene variants to winter depression
Findings suggest that PER3 gene variants prevent adrenal adaptation to winter daylight, leading to serotonin disruption and depression-like behaviors. A recent study in Nature Metabolism used humanized mice with modified PERIOD3 gene variants (P415A and H417R) [...]
Quantum Leap for MRI: Atomic Sensors Unlock New Imaging Potential
New atomic sensor technology enhances MRI quality control by tracking hyperpolarized molecules in real-time, with potential benefits for various scientific fields. Magnetic resonance imaging (MRI) is a fundamental tool in modern medicine, offering detailed [...]
MethylGPT unlocks DNA secrets for age and disease prediction
By harnessing advanced AI, MethylGPT decodes DNA methylation with unprecedented accuracy, offering new paths for age prediction, disease diagnosis, and personalized health interventions. In a recent study posted to the bioRxiv preprint* server, researchers developed a [...]
“Astonishing” – Scientists Unveil First Blueprint of the Most Complex Molecular Machine in Human Biology
Researchers unveil the inner mechanisms of the most intricate and complex molecular machine in human biology. Scientists at the Centre for Genomic Regulation (CRG) in Barcelona have developed the first comprehensive blueprint of the [...]
Breakthrough research reveals how to target malignant DNA in aggressive cancers
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments. In three groundbreaking papers published [...]
How bacteria trigger colon cancer
In a recent study published in Nature, scientists used murine models to investigate how certain bacteria, such as Escherichia coli strains that contain a polyketide synthase (pks) island encoding enzymes that produce colibactin genotoxin, could increase the [...]
Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2
(Nanowerk News) Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of [...]
Nanodiscs: What Are They and How Are They Shaping the Future of Medicine?
Nanodiscs are synthetic phospholipid particles with a distinct morphology and size that enhance their efficiency in drug delivery applications.1 First developed by Sligar et al. in the early 2000s, these model membrane systems measure around 10 [...]
New Discovery Reveals How Ovarian Cancer Starves Immune Cells
Researchers discovered that ovarian tumors hinder T cells’ energy supply by trapping a key protein, blocking lipid uptake. A new approach to reprogram T cells could enhance immunotherapy for aggressive cancers. Researchers at Weill Cornell [...]
Innovative Drug-Design Strategies to Overcome Antibacterial Resistance
Antibacterial resistance occurs when antibiotics fail to treat bacterial infections. This incidence is considered one of the top global health threats, stemming from the misuse or overuse of antibiotics in humans and animals.1 The [...]